Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.
about
Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal Kupffer and endothelial cellsbeta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosisThe role of epigenetics in the pathology of diabetic complicationsTobacco smoke is a source of toxic reactive glycation productsNonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetesFibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersOrally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathyHow hyperglycemia promotes atherosclerosis: molecular mechanisms.Influence of diabetes mellitus on heart failure risk and outcomeAssessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directionsTherapeutic modification of arterial stiffness: An update and comprehensive reviewContribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinomaDiabetes mellitus related bone metabolism and periodontal diseasePostprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinideTherapeutic modalities in diabetic nephropathy: standard and emerging approaches.Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factorsStable RAGE-Heparan Sulfate Complexes Are Essential for Signal TransductionAdvanced glycation end products and diabetic complicationsVascular Effects of Dietary Advanced Glycation End ProductsAmadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cellsSerum levels of advanced glycation end products are associated with in-stent restenosis in diabetic patientsRage gene promoter polymorphisms and diabetic retinopathy in a clinic-based population from South IndiaAminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicalsDevelopment and prevention of advanced diabetic nephropathy in RAGE-overexpressing miceA hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular diseaseAlbumin-derived advanced glycation end-products trigger the disruption of the vascular endothelial cadherin complex in cultured human and murine endothelial cellsAdvanced glycation: an important pathological event in diabetic and age related ocular diseaseIncreased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathwaysRk1, a ginsenoside, is a new blocker of vascular leakage acting through actin structure remodelingOncocalyxone A functions as an anti-glycation agent in vitroAdvanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic MiceUrocortin ameliorates diabetic nephropathy in obese db/db miceEvaluation of insulin and ascorbic acid effects on expression of Bcl-2 family proteins and caspase-3 activity in hippocampus of STZ-induced diabetic ratsIdentification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complexCarbonylation contributes to SERCA2a activity loss and diastolic dysfunction in a rat model of type 1 diabetesAdvanced glycated end-products affect HIF-transcriptional activity in renal cellsInhibitory effect of receptor for advanced glycation end products (RAGE) on the TGF-β-induced alveolar epithelial to mesenchymal transitionEvolving pandemic diabetic nephropathyDrugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathologyThe role of lipid peroxidation in arteriosclerosis.
P2860
Q24530074-9D7D79A4-05FC-4254-94F3-041CA492E71FQ24597379-332CAA99-B012-4FC5-A7AB-AB9E07470A30Q24609124-028026C4-6358-4C38-B9E8-4DD4E1224F56Q24623337-8511F3A9-62CF-464E-A249-C02140FAF379Q24627259-F47F6068-AEB4-4F91-9DD4-646CC2D9F343Q24644869-2A7B8432-80D0-48C5-B826-2F8B15463355Q24682750-C0764320-2671-4D1B-89F7-2D5B7419A21BQ24795988-36470E7B-5DA8-40B4-B70D-3D047A3A21D7Q24800363-B1F1D9DD-E349-422D-A018-E3237466761DQ26750574-C24CB5CE-17D3-4FE6-AA73-149319006C86Q26774555-E3DE27D9-744B-4567-85AE-38456CB5A568Q26781477-4E832F8E-691C-4068-97B6-8541AA19A011Q26852990-ACDAA827-0B47-4187-BD43-3F99ECB54FA6Q26865976-DA33DECC-06B6-4DC0-BE7E-AF6E5279A2B3Q27007027-43FB06A3-7855-4A71-ACC1-7226CDD9440DQ27022694-32C9A5B4-90DF-41F7-A832-4AA422CAA45FQ27678167-EC4CD0DC-8FF4-43B1-A76B-0CF31F049452Q27687501-B14914CF-1AE2-4479-BF8F-EE0036E22C8FQ28081090-0AF7EF9D-AE00-4BF5-9E48-EA90517432DBQ28188017-617823F6-91BE-46D8-9B14-478D29CADC78Q28218404-656FE3E2-51E4-43AC-8363-786B27D58F10Q28294038-DE0CCB9F-8EEC-46D1-9955-32D51B6FDB77Q28328519-9A0D86FB-BE27-44BC-95E4-702BF6A892CBQ28344139-6FBD5E0F-5FC0-4CFD-BDA7-07120625EBDDQ28361892-A3EAFC34-4038-40B4-9AEC-4608D331C64BQ28362386-EE5C2692-CF77-4960-9CBF-A8902ABD9561Q28365776-4A4C6BB2-1B32-4DFA-AB9C-107EF5D1F51FQ28385804-B62D4AFD-9BE0-431D-B33F-74EE332EF0ECQ28534764-DA249FA8-5843-4BEC-B9EC-7AE6C80DB882Q28545770-D6D76B81-62A8-4F4F-8053-2091AAA5B51EQ28551744-2DFD3463-974E-4CAD-B66A-91BF90BFA59BQ28573393-04A83698-9CE0-4273-ACCE-25BAA83A25E6Q28574964-E93338F7-DC68-4545-839A-21AD1F6EAF1EQ28577438-E44A1C95-0D0A-45BC-A105-A6F84B3CD006Q28577628-8F0F32A0-18BE-4AF4-8378-1BC627771F0BQ28591845-0ADC3E87-2117-41B7-B5FB-F2F29F0DB34EQ29346955-B5DFA05B-85FC-456A-940D-4FC8ADC2A5AEQ30352538-69E704FD-D55E-4B06-B237-865B57C9F6F0Q30434143-ED0DA715-B4E5-40C7-BA2F-BCE47EEC9716Q30441742-A735D77F-976B-4A18-ACB4-C853D3E3A949
P2860
Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Advanced glycosylation end pro ...... sis of diabetic complications.
@ast
Advanced glycosylation end pro ...... sis of diabetic complications.
@en
Advanced glycosylation end pro ...... sis of diabetic complications.
@nl
type
label
Advanced glycosylation end pro ...... sis of diabetic complications.
@ast
Advanced glycosylation end pro ...... sis of diabetic complications.
@en
Advanced glycosylation end pro ...... sis of diabetic complications.
@nl
prefLabel
Advanced glycosylation end pro ...... sis of diabetic complications.
@ast
Advanced glycosylation end pro ...... sis of diabetic complications.
@en
Advanced glycosylation end pro ...... sis of diabetic complications.
@nl
P2093
P1476
Advanced glycosylation end pro ...... sis of diabetic complications.
@en
P2093
P304
P356
10.1056/NEJM198805193182007
P407
P577
1988-05-01T00:00:00Z